Urinary Tract Infections Due to Candida albicans
The DOI matches its Crossref record.
Abstract
Infection of the urinary tract due to Candida albicans is an uncommon but well-described complication of modern therapeutics. Despite the rarity of this infection, culture of properly collected urine yielding C. albicans requires an explanation. The significance of systemic factors in the defense of the urinary tract against candidal infection is unknown, but secretions from the prostate gland in men and from periurethral glands in women have been reported to be fungistatic. In addition, growth of Candida at sites on mucous membranes may be suppressed by other normal flora. Conditions that predispose to candiduria include diabetes mellitus, antibiotic and corticosteroid therapy, as well as factors such as local physiology and disturbance of urine flow. Lower urinary tract candidiasis is usually the result of a retrograde infection, while renal parenchymal infection most often follows candidemia. In addition to asymptomatic candiduria, recognized clinical forms of candidal urinary tract infections include bladder infection, renal parenchymal infection, and infections associated with fungus ball formation. Unfortunately, clinical criteria alone are insufficient to distinguish reliably among these clinical types. If the urine is found to contain candidal organisms, the condition of the patient should be considered for determination of appropriate therapy. When infection is thought to be confined to the bladder, patients without indwelling bladder catheters should be considered for flucytosine therapy. For patients requiring indwelling bladder catheterization, irrigation with amphotericin B is usually successful. Although flucytosine alone may be useful for renal parenchymal candidal infection, iv amphotericin B alone or the combination of amphotericin B and flucytosine is indicated when systemic candidiasis cannot be excluded.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Amphotericin B: 30 Years of Clinical Experience
Gallis, H. A., Drew, R. H., & Pickard, W. W. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.308 · Cited by 1,009
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 498
Prospective Multicenter Surveillance Study of Funguria in Hospitalized Patients
Kauffman, C. A., Vazquez, J. A., Sobel, J. D., Gallis, H. A., McKinsey, D. S., Karchmer, A. W., Sugar, A. M., Sharkey, P. K., Wise, G. J., Mangi, R., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313583 · Cited by 483
“It is presumed that antibiotics change the normal flora of the perineum, allowing overgrowth of yeasts with subsequent ingress along the urethra and colonization and/or infection of the bladder [16].”
BackgroundCandiduria: A Randomized, Double-Blind Study of Treatment with Fluconazole and Placebo
Sobel, J. D., Kauffman, C. A., McKinsey, D., Zervos, M., Vazquez, J. A., Karchmer, A. W., Lee, J., Thomas, C., Panzer, H., Dismukes, W. E., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313580 · Cited by 343
“Physicians are inconsistent because they do not always understand the clinical significance of this finding, because they lack information about the natural history of asymptomatic candiduria, and are often unwilling to administer systemic amphotericin B [12, 15-17].”
BackgroundRisk factors for nosocomial candidemia: A case-control study in adults without leukemia☆
Bross, J., Talbot, G. H., Greg, M., Shelley, H., & Strom, B. L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90719-5 · Cited by 275
Nosocomial Candiduria: A Review
Weinstein, R. A., Lundstrom, T., & Sobel, J. (2001) · Clinical Infectious Diseases · doi:10.1086/320531 · Cited by 221
Invasive candidiasis in immunocompromised hospitalized patients.
Sims, C. R., Ostrosky-Zeichner, L., & Rex, J. H. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.05.015 · Cited by 124
Vazquez, J. A., & Sobel, J. D. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00042-9 · Cited by 104
Leu, H.-S., & Huang, C.-T. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1152 · Cited by 93
“The increase in its incidence is probably related to the increasing frequencies of urinary catheterization; treatment with broad-spectrum antibiotics, steroids, immunosuppressive agents, and antineoplastic drugs; radiation therapy; many debilitating diseases, such as diabetes mellitus; and extreme old age [1].”
BackgroundFungal Infections of the Genitourinary System
Wise, G. J., & Silver, D. A. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)36396-6 · Cited by 85
Metadata
- Authors
- Fisher, J. F., Chew, W. H., Shadomy, S., Duma, R. J., Mayhan, C. G., & House, W. C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1982-11-01
- Volume
- 4
- Issue
- 6
- Pages
- 1107-1118
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2042607327
- Cited by
- 158
- References
- 0
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.